| |
| |
|
| Insider
Information: |
Snodgrass H. Ralph |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
64,958 |
|
|
Indirect Shares
|
33,901 |
|
|
| Direct
Value |
$250,738 |
|
|
|
Indirect Value
|
$130,858 |
|
|
| Total
Shares |
98,859 |
|
|
| Total
Value |
$381,596 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -53.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vistagen Therapeutics Inc |
VTGN |
|
2021-12-31 |
64,958 |
2021-12-31 |
33,901 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-12-31 |
4 |
A |
$1.66 |
$6,005 |
D/D |
3,623 |
64,958 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-09-02 |
4 |
GA |
$0.00 |
$0 |
D/D |
1,111 |
61,335 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-08-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
740 |
33,901 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-08-17 |
4 |
B |
$2.73 |
$10,238 |
I/I |
3,750 |
34,641 |
0.01 |
% |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2021-06-30 |
4 |
A |
$1.95 |
$6,601 |
D/D |
3,391 |
91,115 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• • – |
2020-06-30 |
4 |
A |
$0.45 |
$2,240 |
D/D |
5,000 |
67,724 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• • – |
2019-03-13 |
4 |
OE |
$1.50 |
$3,750 |
D/D |
2,500 |
62,724 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• • – |
2011-12-20 |
4 |
OE |
$0.88 |
$100,000 |
D/D |
113,636 |
1,204,468 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2011-05-11 |
4 |
A |
$3.50 |
$1,908,956 |
D/D |
545,416 |
545,416 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
